Rix-Fp, a Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin, Improves Kinetics in Cynomolgus Monkeys and Hemophilia B Dogs

被引：0
|
作者：
Nolte, Marc Wolfgang [1 ]
Nichols, Timothy Charles [2 ]
Mueller-Cohrs, Jochen [1 ]
Merricks, Elizabeth Parker [2 ]
Pragst, Ingo [1 ]
Zollner, Sabine [1 ]
Dickneite, Gerhard [1 ]
机构：
[1] CSL Behring GmbH, Preclin Res & Dev, Marburg, Germany
[2] Univ N Carolina, Dept Pathol & Lab Med, Francis Owen Blood Res Lab, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2012年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [31] Efficacy, PK and safety results of a Phase I/II clinical study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B
    Martinowitz, U.
    Lubetsky, A.
    Santagostino, E.
    Jotov, G.
    Brutman-Barazani, T.
    Voigt, C.
    Moises, T.
    Jacobs, I
    Lissitchkov, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 240 - 241
  • [32] Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Adolescent and Adult Patients with Hemophilia B: Efficacy and Safety from a Phase 3 Pivotal Clinical Trial
    Santagostino, E.
    Martinowitz, U.
    Lissitchkov, T.
    Pan-Petesch, B.
    Hanabusa, H.
    Oldenburg, J.
    Boggio, L.
    Negrier, C.
    Pabinger, I.
    Prondzinski, M. Von Depka
    Altisent, C.
    Castaman, G.
    Yamamoto, K.
    Alvarez-Roman, M. -T.
    Voigt, C.
    Jacobs, I.
    HAEMOPHILIA, 2016, 22 : 61 - 62
  • [33] Safety and pharmacokinetic results of a phase I/II clinical trial of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B (PROLONG-9FP)
    Lubetsky, A.
    Lissitchkov, T.
    Yotov, G.
    Luboshitz, J.
    Lelazari, S.
    Barazani-Brutman, T.
    Santagostino, E.
    Voigt, C.
    Zanette, M.
    Jacobs, I.
    Martinowitz, U.
    HAEMOPHILIA, 2012, 18 : 24 - 24
  • [34] UPDATED POPULATION PHARMACOKINETIC ANALYSIS FOR NEW DOSING REGIMENS OF RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PEDIATRIC PATIENTS WITH HEMOPHILIA B.
    Zhang, Y.
    McKeand, W.
    Roberts, J.
    Goldstein, B.
    Tortorici, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S104 - S104
  • [35] Pharmacokinetic Results of Two Phase III Clinical Studies of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B (PROLONG-9FP)
    Santagostino, Elena
    Jacobs, Iris C.
    Voigt, Christine
    Feussner, Annettee
    Limsakun, Tharin
    BLOOD, 2014, 124 (21)
  • [36] Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B
    Martinowitz, Uri
    Lubetsky, Aaron
    THROMBOSIS RESEARCH, 2013, 131 : S11 - S14
  • [37] Pharmacokinetic (PK) results of two Phase III clinical studies of coagulation factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in previous treated patients with hemophilia B (PROLONG-9FP)
    Santagostino, Elena
    Jacobs, Iris
    Voigt, Christine
    Feussner, Annette
    Limsakun, Tharin
    Easton, Rachael
    HAEMOPHILIA, 2014, 20 : 15 - 15
  • [38] ANALYSIS OF EXTENDED DOSING REGIMENS WITH RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PAEDIATRIC PATIENTS WITH HAEMOPHILIA B: A POPULATION PHARMACOKINETIC SIMULATION
    McKeand, W.
    Roberts, J.
    Yuraszeck, T.
    Goldstein, B.
    Tortorici, M. A.
    HAEMOPHILIA, 2021, 27 : 42 - 43
  • [39] Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial
    Pabinger, Ingrid
    Santagostino, Elena
    Brainsky, Andres
    Powell, Jerry S.
    Li, Yanyan
    Seifert, Wilfried
    BLOOD, 2017, 130
  • [40] Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study
    Kenet, Gili
    Chambost, Herve
    Male, Christoph
    Halimeh, Susan
    Lambert, Thierry
    Li, Yanyan
    Seifert, Wilfried
    Santagostino, Elena
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (04) : 599 - 606
12345